Hortobagyi GN - Search Results

1

Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis.

Niikura N, Liu J, Hayashi N, Palla SL, Tokuda Y, Hortobagyi GN, Ueno NT, Theriault RL. Niikura N, et al. Among authors: hortobagyi gn. Oncologist. 2011;16(2):155-64. doi: 10.1634/theoncologist.2010-0350. Epub 2011 Jan 25. Oncologist. 2011. PMID: 21266401 Free PMC article.

2

Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.

Walters RS, Theriault RL, Holmes FA, Hortobagyi GN, Esparza L. Walters RS, et al. Among authors: hortobagyi gn. Invest New Drugs. 1992 Apr;10(1):43-4. doi: 10.1007/BF01275480. Invest New Drugs. 1992. PMID: 1376723 Clinical Trial.

3

Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.

Buzdar AU, Hortobagyi GN, Kau SW, Smith TL, Fraschini G, Holmes FA, Gutterman JU, Hug VM, Singletary SE, Ames FC, et al. Buzdar AU, et al. Among authors: hortobagyi gn. J Clin Oncol. 1992 Oct;10(10):1540-6. doi: 10.1200/JCO.1992.10.10.1540. J Clin Oncol. 1992. PMID: 1403033 Clinical Trial.

4

Bone metastasis in breast cancer.

Theriault RL, Hortobagyi GN. Theriault RL, et al. Among authors: hortobagyi gn. Anticancer Drugs. 1992 Oct;3(5):455-62. doi: 10.1097/00001813-199210000-00002. Anticancer Drugs. 1992. PMID: 1450438 Review.

5

Activity of ifosfamide in breast cancer.

Hortobagyi GN. Hortobagyi GN. Semin Oncol. 1992 Dec;19(6 Suppl 12):36-41. Semin Oncol. 1992. PMID: 1485173 Review.

6

Treatment of locally advanced breast cancer.

Booser DJ, Hortobagyi GN. Booser DJ, et al. Among authors: hortobagyi gn. Semin Oncol. 1992 Jun;19(3):278-85. Semin Oncol. 1992. PMID: 1609294 Review.

7

Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer.

Ziegler LD, Connelly JH, Frye D, Smith TL, Hortobagyi GN. Ziegler LD, et al. Among authors: hortobagyi gn. Cancer. 1991 Aug 1;68(3):628-33. doi: 10.1002/1097-0142(19910801)68:3<628::aid-cncr2820680331>3.0.co;2-3. Cancer. 1991. PMID: 1648436

8

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Holmes FA, et al. Among authors: hortobagyi gn. J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805. doi: 10.1093/jnci/83.24.1797-a. J Natl Cancer Inst. 1991. PMID: 1683908 Clinical Trial.

9

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

10

A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma.

Walters RS, Frye D, Buzdar AU, Holmes FA, Hortobagyi GN. Walters RS, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):476-81. doi: 10.1002/1097-0142(19920115)69:2<476::aid-cncr2820690234>3.0.co;2-0. Cancer. 1992. PMID: 1728377 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters